
Contineum Therapeutics, Inc. Class A Common Stock
USD12.48
+0.10 (+0.81%)
CEO
Carmine N. Stengone
IPO Date
2024-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.43
Prev. Close
$12.38
Day Low
$12.20
Day High
$12.79
52W Low
$3.57
52W High
$16.33
Market Cap
$0.47B
Volume
0.43M
| 24 Nov 2025 |
| Baird |
| Outperform |
| Outperform |
| maintain |
| 21 Nov 2025 | RBC Capital | Outperform | Outperform | maintain |
| 18 Aug 2025 | Morgan Stanley | Overweight | Overweight | maintain |
| 19 May 2025 | Morgan Stanley | Overweight | Overweight | maintain |
| 15 May 2025 | RBC Capital | Outperform | Outperform | maintain |
| 7 Mar 2025 | Baird | Outperform | Outperform | maintain |
| 9 Jan 2025 | RBC Capital | Outperform | Outperform | maintain |